Choriogonadotropin alfa biosimilar - Dong-A ST
Alternative Names: DA 3803; r-hCGLatest Information Update: 02 Oct 2021
Price :
$50 *
At a glance
- Originator Dong-A Pharmaceutical
- Developer Dong-A ST
- Class Gonadotropins; Infertility therapies; Peptide hormones; Pituitary gonadotropins; Placental hormone vaccines; Placental hormones; Recombinant proteins
- Mechanism of Action Ovarian follicle stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes - Female infertility
Highest Development Phases
- No development reported Female infertility
Most Recent Events
- 11 Sep 2018 No development reported - Preregistration for Female infertility in South Korea (SC)
- 26 May 2015 Choriogonadotropin alfa biosimilar - Dong-A ST is available for licensing in World as of 26 May 2015. http://en.donga-st.com
- 26 May 2015 Dong A announces intention to submit NDA to KFDA (Dong-A ST 1Q report, May 2015)